CCS
CMD

Crosspoint Capital Strategies’s Cantel Medical Corporation CMD Stock Holding History

Crosspoint Capital Strategies’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-91
Closed -$7K – 190
2016
Q3 		$7K Hold
91
– – 0.01% 83
2016
Q2 		$6K Hold
91
– – 0.01% 98
2016
Q1 		$6K Buy
+91
New +$5.71K 0.01% 103
2015
Q3 		– Sell
-200
Closed -$11K – 920
2015
Q2 		$11K Buy
+200
New +$9.73K ﹤0.01% 502

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Crosspoint Capital Strategies's CMD Position: Q4 2016 in Review

Crosspoint Capital Strategies sold out of Cantel Medical Corporation (CMD) in Q4 2016, closing a stake of 91 shares — an estimated $7K sold.

Crosspoint Capital Strategies first reported a position in CMD in Q2 2015 and held it in 4 quarters. The position peaked at $11K in Q2 2015. 234 funds tracked by Wall St. Rank hold CMD as of Q4 2016.

  • Crosspoint Capital Strategies reported no remaining Cantel Medical Corporation position as of Q4 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 91 Cantel Medical Corporation shares in Q4 2016, an estimated $7K.
  • Crosspoint Capital Strategies first reported a position in Cantel Medical Corporation in Q2 2015 and held it in 4 quarters.
  • Crosspoint Capital Strategies's Cantel Medical Corporation position peaked at $11K in Q2 2015.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2016, filed 23 Jan 2017.